BUY Angel One Ltd — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: 1–3 months27 Aug 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·25 Aug · 5d ago
Groww leads India's top brokerages in July with over 70,000 new active accounts
NewsEt-Markets·13 Aug · 3w ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock
Advisor consensus · same horizon·16 Jul · 2mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Angel One
- BUY — ICICI Securities19 Oct 2026 · ~1 year · target ₹347 · Active
- BUY — HDFC Securities19 Oct 2026 · ~1 year · target ₹390 · Active
- BUY — Manas Jaiswal16 Oct 2026 · Same day · target ₹330 · SL hit
- BUY — Aastha Jain, Hem Securities16 Oct 2026 · Same day · target ₹325 · SL hit
- BUY — J.P. Morgan16 Oct 2026 · ~1 year · target ₹370 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

